Head of Investor Relations
Arcutis Biotherapeutics, Inc. (ARQT)Equibles does not estimate personal net worth.
Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARQT alertsEric McIntyre is recorded as Head of Investor Relations at Arcutis Biotherapeutics, Inc. (ARQT). Eric McIntyre has spoken on 4 earnings calls across 1 company, most recently for Arcutis Biotherapeutics, Inc. on November 3, 2023. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Todd Franklin Watanabe (CEO and Board Member), Latha Vairavan (CFO), Masaru Matsuda (General Counsel) and 7 others.
“Good morning, everyone, and thank you for joining this morning to discuss our Q3 2023 financial results. The slides for today are available on the Investors section of our website.”
“Good afternoon, everyone, and thank you for joining our Arcutis second quarter earnings call. Slides for today are available on the Investors section of our website.”
“Good afternoon, everyone, and thank you for joining Arcutis' First Quarter 2023 Earnings Call. Slides for today are available on the Investors section of our website.”
“Good afternoon, everyone, and thank you for joining Arcutis' fourth quarter and full year 2022 earnings call. Slides are available on the Investors section of our website.”
Biotechnology · Healthcare
Head of Investor Relations
